Creating an Indian Super Brand: The Thyrocare Story by Dr. A Velumani

Thyrocare is India’s first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries. Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai – India  and Regional Processing Laboratory in major metro cities of India and other parts of Asia. Thyrocare focuses on strong technologies, strong brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost. With a belief that ‘Quality’ is the heart of any intelligent management, Thyrocare became one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations like ISO 9001-2000 rating as early as 2001, which is now escalated to ISO 9001:2008 and CAP (College of American Pathologists) certification in 2007.

About the Speaker:

Arokiaswamy Velumani is an Indian scientist and entrepreneur. He is the founder, chairman and managing director of Thyrocare Technologies Ltd. a chain of diagnostic and preventive care laboratories headquartered in Navi Mumbai. He is the founder and managing director of Nueclear Healthcare Limited, a radiology diagnostics company affiliated to Thyrocare.

After graduating, Velumani began with a job at Gemini Capsules, a small pharmaceutical company in Coimbatore, Tamil Nadu as a shift chemist. After three years, the company was shut down. He then worked at Bhabha Atomic Research Centre (BARC) first as a laboratory assistant, staying for 14 years. During this time he pursued his Master’s and Doctor’s degree and rose to the rank of scientist. He later was posted at the Radiation Medicine Centre (RMC), a BARC department at Tata Memorial Hospital in Parel, Mumbai, Maharashtra.

Velumani decided to set up his own thyroid testing laboratory, Thyrocare, in 1996. He introduced a franchisee model in his diagnostic laboratory and offered affordable testing services. Thyrocare expanded from testing for thyroid disorders to preventive medical checkups and other diagnostic blood tests.

Under his leadership Thyrocare became the largest thyroid testing laboratory, with a network of more than 1000 outlets across India, Nepal, Bangladesh and the Middle East. In April 2016, Thyrocare conducted its Initial Public Offer (IPO) release, achieving over-subscription of 72.86 times.

For more details contact:

Ms. Supriya Patade on 9082205742 – [email protected]  and Ms. Laxmi Gupta on 7738149513 –[email protected]